These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2802424)

  • 1. Tumor necrosis factor induces hemorrhagic necrosis of a sarcoma.
    Robertson PA; Ross HJ; Figlin RA
    Ann Intern Med; 1989 Oct; 111(8):682-4. PubMed ID: 2802424
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tumor necrosis factor].
    Herrmann F; Mertelsmann R
    Dtsch Med Wochenschr; 1989 Feb; 114(8):312-6. PubMed ID: 2646094
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor necrosis factor: still a promising agent.
    Frei E; Spriggs D
    J Clin Oncol; 1989 Mar; 7(3):291-4. PubMed ID: 2645383
    [No Abstract]   [Full Text] [Related]  

  • 4. Radiation-induced fibrosarcoma of the head and neck.
    Mahmoud NA
    J Laryngol Otol; 1980 Feb; 94(2):231-42. PubMed ID: 7373127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human pharmacological investigation of a human recombinant tumor necrosis factor preparation (PAC-4D) a phase-I trial.
    Lenk H; Tanneberger S; Müller U; Shiga T
    Arch Geschwulstforsch; 1988; 58(2):89-97. PubMed ID: 3377652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II multicenter, randomized, double-blind study of recombinant mutated human tumor necrosis factor-α in combination with chemotherapies in cancer patients.
    Li M; Xu T; Zhang Z; Xue X; Zhang C; Qin X; Li W; Hao Q; Zhang W; Zhang Y
    Cancer Sci; 2012 Feb; 103(2):288-95. PubMed ID: 22085427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor: current clinical status and implications for nursing management.
    Moldawer NP; Figlin RA
    Semin Oncol Nurs; 1988 May; 4(2):120-5. PubMed ID: 3287537
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanism of antitumor activity of tumor necrosis factor alpha with hyperthermia in a tumor necrosis factor alpha-resistant tumor.
    Srinivasan JM; Fajardo LF; Hahn GM
    J Natl Cancer Inst; 1990 Dec; 82(24):1904-10. PubMed ID: 2250311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I study of recombinant human tumor necrosis factor (rHu-TNF:PT-050).
    Taguchi T
    Cancer Detect Prev; 1988; 12(1-6):561-72. PubMed ID: 3180146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I dose-escalation study of tumor necrosis factor-alpha and concomitant radiation therapy.
    Hallahan DE; Vokes EE; Rubin SJ; O'Brien S; Samuels B; Vijaykumar S; Kufe DW; Phillips R; Weichselbaum RR
    Cancer J Sci Am; 1995; 1(3):204-9. PubMed ID: 9166477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to tumor necrosis factor in two cases of psoriasis.
    Creaven PJ; Stoll HL
    J Am Acad Dermatol; 1991 May; 24(5 Pt 1):735-7. PubMed ID: 1869645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation-induced fibrosarcoma of the thyroid.
    Tamada A; Makimoto K; Tasaka Y; Nakamoto Y; Iwasaki H; Yamabe H
    J Laryngol Otol; 1984 Oct; 98(10):1063-6. PubMed ID: 6491491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antitumor function of tumor necrosis factor (TNF), I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity.
    Havell EA; Fiers W; North RJ
    J Exp Med; 1988 Mar; 167(3):1067-85. PubMed ID: 3351434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel tumor necrosis factor toxic effects. Pulmonary hemorrhage and severe hepatic dysfunction.
    Schilling PJ; Murray JL; Markowitz AB
    Cancer; 1992 Jan; 69(1):256-60. PubMed ID: 1309306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I clinical trial of recombinant human tumor necrosis factor.
    Creaven PJ; Plager JE; Dupere S; Huben RP; Takita H; Mittelman A; Proefrock A
    Cancer Chemother Pharmacol; 1987; 20(2):137-44. PubMed ID: 3664933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of tumor necrosis factor (cachectin) in cachexia.
    Oliff A
    Cell; 1988 Jul; 54(2):141-2. PubMed ID: 3292054
    [No Abstract]   [Full Text] [Related]  

  • 17. [A case of radiation-induced intracranial fibrosarcoma with repeated episodes of intratumoral hemorrhage].
    Yamamoto A; Hashimoto N; Yamashita J; Kikuchi H
    No Shinkei Geka; 1989 Feb; 17(2):193-6. PubMed ID: 2733814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radiation-induced sarcoma of the skull].
    Friedmann G; Kleinsasser O
    Strahlentherapie; 1969 Jan; 137(1):33-7. PubMed ID: 4305843
    [No Abstract]   [Full Text] [Related]  

  • 19. A phase I clinical trial of recombinant human tumor necrosis factor.
    Creagan ET; Kovach JS; Moertel CG; Frytak S; Kvols LK
    Cancer; 1988 Dec; 62(12):2467-71. PubMed ID: 3191449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical studies with tumour necrosis factor.
    Spriggs DR; Sherman ML; Frei E; Kufe DW
    Ciba Found Symp; 1987; 131():206-27. PubMed ID: 3330011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.